AMP Capital Investors’s Orthofix Medical OFIX Stock Holding History

AMP Capital Investors’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,586	Closed	-$374K	–	1179
2018 Q2	$374K	Sell	6,586 -900	-12%	-$51.2K	﹤0.01%	1037
2018 Q1	$436K	Buy	+7,486	New	+$419K	﹤0.01%	1015
2013 Q3	–	Sell	-17,660	Closed	-$469K	–	1265
2013 Q2	$469K	Buy	+17,660	New	+$529K	﹤0.01%	1078

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AMP Capital Investors's OFIX Position: Q3 2018 in Review

AMP Capital Investors sold out of Orthofix Medical (OFIX) in Q3 2018, closing a stake of 6,586 shares — an estimated $374K sold.

AMP Capital Investors first reported a position in OFIX in Q2 2013 and held it in 3 quarters. The position peaked at $469K in Q2 2013. 162 funds tracked by Wall St. Rank hold OFIX as of Q3 2018.

AMP Capital Investors reported no remaining Orthofix Medical position as of Q3 2018 after selling out during the quarter.
AMP Capital Investors sold 6,586 Orthofix Medical shares in Q3 2018, an estimated $374K.
AMP Capital Investors first reported a position in Orthofix Medical in Q2 2013 and held it in 3 quarters.
AMP Capital Investors's Orthofix Medical position peaked at $469K in Q2 2013.
162 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2018.

Based on AMP Capital Investors's 13F filing for Q3 2018, filed 13 Nov 2018.